Filter
196
Filtered Results: 196
Text search:
Treatment
Action
Group
(TAG)
Featured
Recommendations
14
New Publications
44
Language
Document type
No document type
109
Studies & Reports
33
Guidelines
25
Manuals
9
Strategic & Response Plan
9
Training Material
6
Fact sheets
3
Brochures
1
Infographics
1
Countries / Regions
India
13
South Africa
8
Global
8
Latin America and the Carribbean
7
Kenya
6
Western and Central Europe
6
Zambia
4
Liberia
3
Ethiopia
3
Nepal
3
Germany
3
Myanmar / Burma
3
Guinea
2
Congo, Democratic Republic of
2
Uganda
2
Pakistan
2
Afghanistan
2
Tanzania
2
Bangladesh
2
South–East Asia Region
2
Asia
2
Sierra Leone
1
Nigeria
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Ghana
1
South Sudan
1
Iraq
1
Lebanon
1
Syria
1
Chad
1
Rwanda
1
Angola
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Africa
1
Tajikistan
1
Iran
1
Authors & Publishers
Publication Years
Category
Countries
60
Clinical Guidelines
19
Women & Child Health
12
Key Resources
10
Public Health
9
Capacity Building
7
Pharmacy & Technologies
2
Toolboxes
TB
28
HIV
20
Mental Health
11
COVID-19
11
Caregiver
9
AMR
8
Rapid Response
6
Disability
5
NTDs
5
Refugee
4
Global Health Education
4
Pharmacy
4
Conflict
3
Planetary Health
3
Ebola
2
Cholera
2
Zika
2
Polio
1
Natural Hazards
1
Specific Hazards
1
Health Financing Toolbox
1
NCDs
1
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Prepared for the Stunting Prevention and Reduction Project - The project Medical Waste Management Plan’s (MWMP) overall objective is to prevent and/or mitigate the negative effects of increased generation of medical waste on human health and the environment. The plan proposes measures to prevent t...
A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current level of response, people would use this manual in di...
Facilitator's Guide. This guide is designed to assist facilitators in training community health workers (CHWs) and community volunteers (CVs) in integrating community-based TB services into their work. The training will help community workers who already provide numerous services to understand TB an...
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
Intégrer les activités communautaires de lutte contre la tuberculose dans le travail des ONG et des autres organisations de la société civile
Guide de l’animateur
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
This Toolkit aims to support the understanding and implementation of integrated mental health programs in humanitarian settings. It provides a framework for essential steps and components, with associated key guidance and resources, that strengthen the integration process, and is primarily intended ...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
Supplement Article
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018 www.jaids.com
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
10–11 May 2016, Catania, Italy
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
